Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Invitae acquires perinatal testing firm Good Start for $40mm

Executive Summary

Invitae Corp.'s plan to acquire private molecular diagnostics company Good Start Genetics Inc. (perinatal tests) for $40mm is the second transaction in the reproductive health space announced by the public firm this month; it concurrently entered into an agreement to buy CombiMatrix (fertility and perinatal health testing) for $33.6mm.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Includes Contract
    • Intra-Biotech Deal
    • Full Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register